论文部分内容阅读
目的探讨NCPAP治疗继发性新生儿呼吸暂停的疗效。方法总结我院2007.01～2008.08新生儿科及ICU收治的继发性呼吸暂停病例81例(不包括继发于呼吸窘迫综合征病例15例),分NCPAP治疗组25例、机械通气治疗组16例、氨茶碱一般治疗组40例三组治疗,回顾性分析疗效情况。结果NCPAP组好转时间短于一般治疗组,t=4.13,P<0.01,差异有显著性,疗效优于一般治疗组;NCPAP组与气管插管组比较,t=0.9,P>0.05,差异无显著性,疗效相似。结论应用NCPAP可有效治疗新生儿呼吸暂停,减少气管插管机会。
Objective To investigate the efficacy of NCPAP in the treatment of secondary neonatal apnea. Methods 81 cases of secondary apnea (excluding 15 cases of secondary respiratory distress syndrome) admitted to neonatology department and ICU from 2007.01 to 2008.08 in our hospital were divided into NCPAP group (25 cases), mechanical ventilation group (16 cases) Aminophylline general treatment group of 40 cases of three groups of treatment, a retrospective analysis of efficacy. Results The improvement time of NCPAP group was shorter than that of general treatment group (t = 4.13, P <0.01), and the difference was significant. The curative effect was better than that of general treatment group. There was no significant difference between NCPAP group and tracheal intubation group Significance, similar efficacy. Conclusion The application of NCPAP can effectively treat neonatal apnea and reduce the chance of tracheal intubation.